Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

GenLife

Financiado

Genetics across the lifespan: Unraveling age-specific determinants of severe men...

Genetics across the lifespan: Unraveling age-specific determinants of severe mental illness Mental disorders affect 1 in every 8 people in the world right now. Genetic predisposition plays a crucial role in the development of severe mental disorders. Genome-wide association studies (GWAS) revolutionized the field of psyc... ver más

31/07/2026

Innovasjon Norge

227K€

Presupuesto del proyecto: 227K€

Líder del proyecto

Innovasjon Norge No se ha especificado una descripción o un objeto social para esta compañía.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-05-22

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023

I+D

Cerrada hace 1 año

0% 100% 100%

1 Participantes

Innovasjon Norge

226.75K€ | Lider

Proyectos interesantes

PSI2017-87512-C2-2-R ANALISIS GENOMICO DEL EFECTO MODERADOR DE VARIACION COMUN EN... 29K€ Cerrado

SAF2012-33484 ANALISIS CRUZADO DE TRASTORNOS PSIQUIATRICOS: CONTRIBUCION D... 140K€ Cerrado

PID2021-125017OB-I00 HACIA UNA COMPRENSION MULTIFACETICA DE LA SALUD MENTAL BASAD... 121K€ Cerrado

SAF2015-68341-R GENETICA Y EPIGENETICA DE TRASTORNOS PSIQUIATRICOS: TRASTORN... 218K€ Cerrado

RTI2018-100968-B-I00 PAISAJE GENETICO DEL TDAH, LOS TRASTORNOS DEL ESPECTRO AUTIS... 145K€ Cerrado

RTI2018-098983-B-I00 REVISANDO LA REPLICABILIDAD GENETICA MEDIANTE UN ENFOQUE MUL... 115K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 26 meses Fecha Inicio: 2024-05-22
Fecha Fin: 2026-07-31

Líder del proyecto

Innovasjon Norge

Presupuesto del proyecto 227K€

Descripción del proyecto Mental disorders affect 1 in every 8 people in the world right now. Genetic predisposition plays a crucial role in the development of severe mental disorders. Genome-wide association studies (GWAS) revolutionized the field of psychiatric genomics by identifying the individual effects of millions of common genetic variants on behavioral, cognitive, and clinical traits. However, current GWAS provide a static snapshot of genetic influences and thus misses the rich tapestry of genetic effects that unfold across an individual's lifespan. Funded by the Marie Skłodowska-Curie Actions program, the GenLife project aims to uncover novel genetic variants with age-dependent effects that have remained hidden until now. Revealing age-specific determinants of severe mental illness across the lifespan will promote the development of more effective, biology-based prediction tools tailored to individuals' disease trajectories. By providing timely support and intervention, mental health professionals will be able to identify and address emerging mental health issues before they escalate into more severe conditions. The GenLife project is based on the synergy between the applicant's highly interdisciplinary profile, cutting-edge research at the host institution, and unique Nordic resources. It will be completed at world-leading research institutions, the University of Oslo and the Norwegian Centre for Mental Disorders Research (NORMENT), under the supervision of Prof. Ole A. Andreassen. Expanding the applicant's line of research, academic maturity, and professional networks will enhance the development of his career as an independent researcher.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores